BackBioTech Medics Overview

BioTech Medics Long Term Debt

Latest long-term debt for BMCS: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

BioTech Medics Long Term Debt History

Loading

BioTech Medics vs. peers: Long Term Debt Comparison

Loading

BioTech Medics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioTech Medics (BMCS) FAQ

BioTech Medics (BMCS) currently reports a long-term debt of $0 as of March 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore BioTech Medics's long-term debt history and peer comparisons.

BioTech Medics's long-term debt changed from $0 to $0 (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioTech Medics reported $0 in long-term debt as of March 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioTech Medics, and consider following BMCS for alerts when major investors trade the stock.